BRPI0519139A2 - liberaÇço controlada de entidades biolàgicas - Google Patents

liberaÇço controlada de entidades biolàgicas

Info

Publication number
BRPI0519139A2
BRPI0519139A2 BRPI0519139-4A BRPI0519139A BRPI0519139A2 BR PI0519139 A2 BRPI0519139 A2 BR PI0519139A2 BR PI0519139 A BRPI0519139 A BR PI0519139A BR PI0519139 A2 BRPI0519139 A2 BR PI0519139A2
Authority
BR
Brazil
Prior art keywords
controlled release
biological entity
biological entities
biological
polar phase
Prior art date
Application number
BRPI0519139-4A
Other languages
English (en)
Portuguese (pt)
Inventor
David Jacques
Kim Suzanne Finnie
Christophe Jean Alexandre Barbe
Linggen Kong
Original Assignee
Australian Nuclear Science Tech Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004907219A external-priority patent/AU2004907219A0/en
Application filed by Australian Nuclear Science Tech Org filed Critical Australian Nuclear Science Tech Org
Publication of BRPI0519139A2 publication Critical patent/BRPI0519139A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/06—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a liquid medium
    • B01J2/08—Gelation of a colloidal solution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21001—Chymotrypsin (3.4.21.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21062—Subtilisin (3.4.21.62)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01005—Urease (3.5.1.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BRPI0519139-4A 2004-12-20 2005-12-20 liberaÇço controlada de entidades biolàgicas BRPI0519139A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2004907219A AU2004907219A0 (en) 2004-12-20 Controlled release of biological entities
PCT/AU2005/001915 WO2006066317A1 (en) 2004-12-20 2005-12-20 Controlled release of biological entities

Publications (1)

Publication Number Publication Date
BRPI0519139A2 true BRPI0519139A2 (pt) 2008-12-30

Family

ID=36601253

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519139-4A BRPI0519139A2 (pt) 2004-12-20 2005-12-20 liberaÇço controlada de entidades biolàgicas

Country Status (10)

Country Link
US (2) US8992986B2 (enExample)
EP (1) EP1838289B1 (enExample)
JP (2) JP5593030B2 (enExample)
KR (1) KR20070104563A (enExample)
CN (1) CN101106978A (enExample)
BR (1) BRPI0519139A2 (enExample)
CA (1) CA2591344C (enExample)
MX (1) MX2007007373A (enExample)
NZ (1) NZ556082A (enExample)
WO (1) WO2006066317A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6101683A (en) 1998-04-02 2000-08-15 Avery Dennison Corporation Loop fastener, fastener clip including same and loop fastener dispensing tool
WO2009132411A1 (en) * 2008-04-28 2009-11-05 The University Of British Columbia Polymer-free drug delivery system for implantable medical devices
EP2411139A4 (en) * 2009-03-27 2017-01-25 Australian Nuclear Science And Technology Organisation Triggered release
BR112013003505A2 (pt) * 2010-08-16 2021-10-13 Australian Nuclear Science & Technology Organisation Substância particulada, processo para fazer partículas e composição farmacêutica
WO2017114955A2 (en) 2015-12-31 2017-07-06 Universal Diagnostics, S.L. Systems and methods for automated, customizable sample preparation tool, software script, and calibration routine for detection of metabolites and lipids
CN107522868B (zh) * 2017-10-16 2021-01-08 湖北工业大学 环氧纳米二氧化硅/嵌段聚合物复合乳液的制备方法
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
JP7580121B2 (ja) * 2018-08-03 2024-11-11 レモネックス インコーポレイテッド アトピー性疾患の予防または治療用の薬学的組成物
IT202000011803A1 (it) * 2020-05-20 2021-11-20 Hudson River Biotechnology B V Particella multistrato incapsulante una molecola biologicamente attiva

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3850751A (en) * 1973-02-16 1974-11-26 Corning Glass Works Enzymes immobilized on porous inorganic support materials
CH624011A5 (enExample) 1977-08-05 1981-07-15 Battelle Memorial Institute
CA1253129A (en) * 1984-02-09 1989-04-25 Thomas R. Jones Porous inorganic materials
JPH0717371B2 (ja) * 1986-09-05 1995-03-01 株式会社資生堂 球状の有機複合粘土鉱物及びその製造法
JPH05261274A (ja) * 1992-03-23 1993-10-12 Lion Corp 金属化合物の球形粒子の製造方法
JP3310291B2 (ja) 1992-08-13 2002-08-05 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 骨組織のｉｎ ｖｉｔｒｏ合成のための生物活性物質テンプレート
US5817327A (en) 1994-07-27 1998-10-06 The Trustees Of The University Of Pennsylvania Incorporation of biologically active molecules into bioactive glasses
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein
US6764690B2 (en) 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
US5972384A (en) 1997-10-01 1999-10-26 University Of Maryland, Baltimore Use of biologically active glass as a drug delivery system
EP1104287B9 (en) 1998-08-13 2012-12-19 Sol-Gel Technologies Ltd. Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof
AU772153B2 (en) 1999-02-12 2004-04-08 Molecular Insight Pharmaceuticals, Inc. Matrices for drug delivery and methods for making and using the same
DE60037883T2 (de) 1999-06-24 2009-02-05 Hogue, Christopher V.W., Etobicoke Einarbeitung und anwendung von biomolekularen wechselwirkungen innerhalb einem trägermittel
JP2001038193A (ja) * 1999-07-28 2001-02-13 Nippon Millipore Kk 複合シリカマイクロカプセルの製造方法と複合シリカマイクロカプセルの芯物質の固定化と徐放作用の制御方法。
AU7881000A (en) 1999-08-16 2001-03-13 Henceforth Hibernia, Inc. Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them
AUPQ573300A0 (en) 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
US6303290B1 (en) 2000-09-13 2001-10-16 The Trustees Of The University Of Pennsylvania Encapsulation of biomaterials in porous glass-like matrices prepared via an aqueous colloidal sol-gel process
US6544497B2 (en) 2001-02-15 2003-04-08 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
US6596262B2 (en) 2001-02-15 2003-07-22 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
US6485707B2 (en) 2001-02-15 2002-11-26 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
CA2465779A1 (en) 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Compositions for sustained action product delivery
JP4192235B2 (ja) * 2002-04-30 2008-12-10 独立行政法人産業技術総合研究所 徐放機能を有するメソポーラス無機材料
AU2003239345A1 (en) * 2002-04-30 2003-11-17 Central Soya Company, Inc. Method of imparting high water dispersibility to protein materials and the products thereof
JP2006506357A (ja) * 2002-10-11 2006-02-23 ヴェクトゥラ　リミテッド 有機高分子物質との組み合わせで無機粒子を含み、かつ固体の網目状マトリックスを形成する医薬賦形剤、その組成物、製造および使用
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
JP2005307120A (ja) * 2004-04-26 2005-11-04 Mitsubishi Chemicals Corp 徐放剤及びそれを用いた徐放材
US20090098044A1 (en) * 2004-11-15 2009-04-16 Australian Nuclear Science And Technology Organisation Solid particles from controlled destabilisation of microemulsions
MX2007005775A (es) * 2004-11-15 2007-08-15 Australian Nuclear Science Tec Particulas solidas provenientes de la desestabilizacion controlada de microemulsiones.

Also Published As

Publication number Publication date
CA2591344C (en) 2015-09-29
WO2006066317A8 (en) 2006-08-24
US20150147401A1 (en) 2015-05-28
JP2013047264A (ja) 2013-03-07
JP5593030B2 (ja) 2014-09-17
MX2007007373A (es) 2007-08-14
NZ556082A (en) 2009-09-25
WO2006066317A1 (en) 2006-06-29
EP1838289A4 (en) 2011-12-14
JP2008538217A (ja) 2008-10-16
US20090252808A1 (en) 2009-10-08
CA2591344A1 (en) 2006-06-29
US9717688B2 (en) 2017-08-01
JP5727445B2 (ja) 2015-06-03
EP1838289A1 (en) 2007-10-03
EP1838289B1 (en) 2017-12-13
US8992986B2 (en) 2015-03-31
KR20070104563A (ko) 2007-10-26
CN101106978A (zh) 2008-01-16

Similar Documents

Publication Publication Date Title
UY30701A1 (es) Sistemas espesados con surfactantes, compuestos de celulosa micro fibrosa, y metodos para fabricarlos
BRPI0718688A8 (pt) Composições de baixa irritação e métodos para preparar as mesmas
BR112014029762A2 (pt) composição contendo n-metil-n-acilglucamina
BR112012011534A2 (pt) materiais de liberação de blenda de fluorossilicone
BR112012006635B8 (pt) composição que compreende partículas de tamanho micro de fosfato de cálcio uniformes, rígidas, esféricas, nanoporosas e método para combinar e separar o solvente não aquoso das referidas partículas
CL2011001419A1 (es) Procedimiento para separar por lo menos un primer material de una mezcla, que comprende contactar la mezcla con una sustancia de superficie activa, tratar la dispersión con partículas magnéticas hidrófobas para que formen aglomerados con el primer material y la sustancia, separar los aglomerados y disociar dichos aglomerados
CL2008002269A1 (es) Composicion util para tratar plantas, que comprende un medio oleoso que contiene particulas de 1- metil - ciclopropeno encapsulado por un agente encapsulador, siendo dichas particulas de 50 micrometros o menos y donde el medio oleoso comprende ademas uno o más dispersante.
BR112012010650A2 (pt) partícula de liberação
BR112016025303A2 (pt) componente de formação de aerossol, dispositivo de liberação de aerossol e método para volatilizar um líquido dentro de um dispositivo de liberação de aerossol
BRPI0912020A2 (pt) composições e métodos de incorporação de fotocatalisadores
BR112012011248A2 (pt) processo para separar pelo menos um primeiro material de uma mistura
ES2722923T3 (es) Procedimiento para preparar una emulsión de partículas de azufre elemental
BR112015020098A2 (pt) método e composição para coloração e processamento de amostras
BR112015029254A2 (pt) composição detergente de baixo ph compreendendo tensoativos não iônicos
BRPI0519139A2 (pt) liberaÇço controlada de entidades biolàgicas
BR112015012670A2 (pt) composições de liberação controlada e métodos de uso
MX363379B (es) Formulaciones tópicas estabilizadas que contienen microcápsulas de núcleo-cubierta.
AR075716A1 (es) Separacion magnetica de minerales metalicos no ferrosos por acondicionamiento en multiples etapas
BR112014028691A2 (pt) artigo de coloração de cabelo sólido e solúvel
UY36157A (es) Composiciones pesticidas y procedimientos relacionados con las mismas
NO20075555L (no) Fremgangsmate for fremstilling av fosfolipider
BR112013026183A2 (pt) processo de determinação da concentração em oxigênio intersticial
BR112014004263A2 (pt) composições fixadoras de cabelo
BR112015001664A2 (pt) composição melhorada de protetor solar
BR112013027965A2 (pt) "composição de revestimento, substrato e método para revestir um substrato"

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL